Trials / Unknown
UnknownNCT05151601
Combined Human Milk Oligosaccharides (HMOs) and Probiotics Intervention for Children With Autism
The Effect of a Combination of Human Milk Oligosaccharides (HMOs) and Probiotics on Behavioural Change in Children With Autism Spectrum Disorder (ASD).
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- The University of Queensland · Academic / Other
- Sex
- All
- Age
- 5 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
This research project will investigate if a supplement containing a unique combination of prebiotics and probiotics can influence behaviour in children diagnosed with autism spectrum disorder. The study will use a combination of human milk oligosaccharides (HMOs, prebiotics) and probiotics as an oral powder.This clinical trial will have two consecutive phases. Phase 1A is an 8-week randomised, double-blinded, placebo-controlled trial. Participants will be recruited and randomised (1:1) to receive either the investigational product (treatment group, n=30) or the placebo (control group, n=30). Phase 1B is an 8-week open-label study. All participants that complete Phase 1A will move into Phase 1B (n=60). This allows all participants to receive the investigational product and will provide additional information on increased duration of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Experimental | 2 x sachets per day |
| OTHER | Placebo | 2 x sachets per day |
Timeline
- Start date
- 2022-05-17
- Primary completion
- 2023-04-16
- Completion
- 2023-12-31
- First posted
- 2021-12-09
- Last updated
- 2023-06-28
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT05151601. Inclusion in this directory is not an endorsement.